| Authors: |
Wilson JM; Brigham and Women's Hospital, Harvard Medical School, 45 Francis St., Boston, MA, 02115, USA. jwilson47@mgb.org., Rosenberg SM; Dana-Farber Cancer Institute, Boston, MA, USA.; Weill Cornell Medicine, New York, NY, USA., Crowell KA; Duke University, Durham, NC, USA., Lynch T; Duke University, Durham, NC, USA., Collyar D; Patient Leadership Team, PORTAL Study, Boston, USA.; Patient Advocates in Research, Danville, CA, USA., Basila D; Patient Leadership Team, PORTAL Study, Boston, USA.; Patient Advocates in Research, Danville, CA, USA., Frank ES; Dana-Farber Cancer Institute, Boston, MA, USA.; Patient Leadership Team, PORTAL Study, Boston, USA., Darai S; Dana-Farber Cancer Institute, Boston, MA, USA., Hyslop T; Duke University, Durham, NC, USA.; Thomas Jefferson University, Philadelphia, PA, USA., Valenza C; Dana-Farber Cancer Institute, Boston, MA, USA., Thompson AM; Baylor College of Medicine, Houston, TX, USA., Partridge AH; Dana-Farber Cancer Institute, Boston, MA, USA., Hwang ES; Duke University, Durham, NC, USA., Schreiber KL; Standford University, Palo Alto, CA, USA. |
